tiprankstipranks
Talphera (TLPH)
NASDAQ:TLPH
US Market

Talphera (TLPH) Earnings Dates, Call Summary & Reports

Compare
1,925 Followers

Earnings Data

Report Date
May 19, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
-0.17
Last Year’s EPS
-0.16
Same Quarter Last Year
Based on 3 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Mar 31, 2025
|
% Change Since: 16.00%
|
Next Earnings Date:May 19, 2025
Earnings Call Sentiment|Positive
The earnings call detailed significant progress, including FDA approvals and financial backing, improving the outlook for the NEPHRO CRRT study. However, challenges with initial study sites and uncertainty regarding enrollment timelines were noted.
Company Guidance
During the Talphera Fourth Quarter and Full Year 2024 Financial Results Conference call, significant updates were provided regarding the NEPHRO CRRT study. The company anticipates completing this study by the end of 2025, with an FDA submission for Niyad expected in the first quarter of 2026. A major highlight was the FDA's approval to reduce the trial size from 166 to 70 patients while retaining a 90% power for the primary endpoint. Talphera also secured a private placement investment of up to $14.8 million, structured in three tranches tied to patient enrollment milestones and stock performance. The company aims to achieve 13 enrollment-ready sites by mid-2025, with new protocol changes expected to accelerate patient enrollment. Talphera reported a decrease in combined R&D and SG&A expenses to $3 million for Q4 2024, down from $4.6 million in Q4 2023, and plans to maintain cash operating expenses in the range of $18 million to $19 million for 2025.
Successful FDA Approvals
The FDA approved a reduction in the NEPHRO CRRT study size from 166 patients to 70, while maintaining 90% power for the primary endpoint. Additionally, two major protocol changes were approved, improving patient enrollment criteria.
Private Placement Investment Secured
Talphera secured a private placement investment of up to $14.8 million, contingent on achieving certain milestones, providing necessary capital for the NEPHRO study completion.
Reduction in Operating Expenses
Operating expenses were reduced, with combined R&D and SG&A expenses for Q4 2024 totaling $3 million, down from $4.6 million in Q4 2023.
Expansion of Enrollment-Ready Sites
Talphera increased enrollment-ready sites to eight, with plans to reach 13 by mid-year 2025, potentially increasing patient enrollment rates.
---

Talphera (TLPH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TLPH Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 19, 20252025 (Q1)
- / -
-0.16
Mar 31, 20252024 (Q4)
-0.15 / -0.07
-0.1656.25% (+0.09)
Nov 13, 20242024 (Q3)
-0.19 / -0.13
-0.08-62.50% (-0.05)
Aug 14, 20242024 (Q2)
-0.21 / -0.15
-0.4163.41% (+0.26)
May 14, 20242024 (Q1)
-0.25 / -0.16
-0.7578.67% (+0.59)
Mar 06, 20242023 (Q4)
-0.20 / -0.25
-175.00% (+0.75)
Nov 08, 20232023 (Q3)
-0.28 / -0.08
-0.9491.49% (+0.86)
Aug 10, 20232023 (Q2)
-0.53 / -0.41
9.6-104.27% (-10.01)
May 10, 20232023 (Q1)
-0.79 / -0.75
-1.237.50% (+0.45)
Mar 30, 20232022 (Q4)
-0.51 / -1.00
-1.216.67% (+0.20)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

TLPH Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 31, 2025$0.50$0.53+6.00%
Nov 13, 2024$0.89$0.66-25.84%
Aug 14, 2024$0.86$0.87+1.16%
May 14, 2024$1.02$1.22+19.61%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Talphera (TLPH) report earnings?
Talphera (TLPH) is schdueled to report earning on May 19, 2025, TBA Not Confirmed.
    What is Talphera (TLPH) earnings time?
    Talphera (TLPH) earnings time is at May 19, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TLPH EPS forecast?
          TLPH EPS forecast for the fiscal quarter 2025 (Q1) is -0.17.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis